Zeitschrift für Sexualforschung, published by GEORG THIEME VERLAG KG, is a prominent journal based in Germany that specializes in the multifaceted fields of psychology and reproductive medicine. With an ISSN of 0932-8114 and an E-ISSN of 1438-9460, this journal serves as a crucial platform for disseminating research and advancements in sexual science. It occupies a notable position, ranked in the Q4 category in Psychology (miscellaneous) and Q3 in Reproductive Medicine as of 2023. Despite being categorized in the lower quartiles, the journal's contributions remain essential for understanding the complexities of human sexuality and reproductive health. Its convergence period spanning from 2008 to 2024 signifies a sustained commitment to advancing knowledge in these fields. Researchers, professionals, and students are encouraged to engage with the journal's content to stay informed on contemporary issues, trends, and innovative research in sexual health, enhancing the discourse surrounding psychological and reproductive topics.

Sexual & Reproductive Healthcare, published by Elsevier Ireland Ltd, is a premier academic journal dedicated to advancing knowledge and best practices in the fields of Maternity and Midwifery, as well as Obstetrics and Gynecology. With a strong emphasis on evidence-based research, this journal, ISSN: 1877-5756 and E-ISSN: 1877-5764, holds a notable Q1 ranking in Maternity and Midwifery, and a Q2 ranking in Obstetrics and Gynecology, marking it as a leader in its categories. As of 2023, it is ranked #9 among 43 journals in Nursing - Maternity and Midwifery and #104 among 209 in Medicine - Obstetrics and Gynecology, reinforcing its importance to researchers and practitioners globally. The journal is committed to publishing high-quality articles that address critical issues in sexual and reproductive health, fostering an academic community that drives innovation and supports clinical excellence. Located in the Netherlands, Sexual & Reproductive Healthcare is accessible to a wide audience of researchers, healthcare professionals, and students, facilitating a comprehensive understanding of the complexities involved in reproductive health and enhancing patient care practices.

BMJ Sexual & Reproductive Health is a premier academic journal published by the esteemed BMJ Publishing Group in the United Kingdom. With an ISSN of 2515-1991 and E-ISSN of 2515-2009, this journal stands at the forefront of critical research in the fields of Obstetrics and Gynecology and Reproductive Medicine, reflecting its commitment to delivering high-quality, peer-reviewed content. Recognized for its significant impact, the journal holds a Q1 classification in both disciplines for 2023, with Scopus rankings of 49th in Obstetrics and Gynecology and 26th in Reproductive Medicine, placing it within the top quartiles of these fields. The journal aims to bridge the gap between cutting-edge research and practical application, providing a platform for researchers, professionals, and students to engage with groundbreaking findings and stay updated on best practices in sexual and reproductive health. As an Open Access journal, it ensures that knowledge is freely available to a global audience, further promoting the advancement of science and health care practices.

Contraception and Reproductive Medicine is a prestigious open-access journal published by BMC that has been serving the global community since 2016. With a focus on the latest research and advancements in the fields of contraception and reproductive health, this journal aims to address the challenges and innovations in fertility management, women's health, and sexual education. As an Open Access platform, it provides researchers, professionals, and students unrestricted access to high-quality, peer-reviewed articles, facilitating the dissemination of vital knowledge and findings. Although specific metrics like the impact factor and H-index are unavailable, the journal's commitment to fostering a vibrant academic dialogue ensures it remains an influential resource in reproductive medicine. Located in London, England, Contraception and Reproductive Medicine invites contributions that highlight both clinical practices and policy implications, ultimately aiming to improve reproductive health care worldwide.

Sexual and Reproductive Health Matters is an esteemed open-access journal published by Taylor & Francis Ltd, dedicated to advancing the fields of obstetrics and gynecology as well as reproductive medicine. Since its transition to open access in 2019, the journal has provided a vital platform for disseminating cutting-edge research and innovative practices pertaining to sexual and reproductive health. With a commendable impact reflected by its categorization in the Q1 Quartile for both Obstetrics and Gynecology and Reproductive Medicine as per the 2023 rankings, it ranks prominently at #71 out of 209 in Obstetrics and Gynecology and #34 out of 90 in Reproductive Medicine on Scopus. This journal not only serves as a resource for researchers and practitioners in the United Kingdom but also has a global reach, inviting contributions that address critical issues related to sexual and reproductive health. Positioned at the forefront of current health science discourse, Sexual and Reproductive Health Matters is an essential read for anyone dedicated to improving health outcomes in this vital area.

Gynecologie Obstetrique Fertilite & Senologie, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, serves as a crucial resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2017 and continuing through 2024, this journal provides a platform for the dissemination of impactful research, evidenced by its placement in the Q3 category for both obstetrics and gynecology and reproductive medicine in 2023. Although it currently does not operate under an open-access model, the journal is committed to advancing knowledge and practice in women's health and reproductive issues, ensuring that professionals stay at the forefront of scientific developments. With an ISSN of 2468-7197 and an E-ISSN of 2468-7189, the journal not only supports the global medical community from its base in France but also contributes to the broader academic discourse on critical topics such as fertility and women's health. As researchers and professionals in the field seek to enhance their understanding and impact, Gynecologie Obstetrique Fertilite & Senologie remains an essential publication for quality research and innovative solutions in women’s health.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

Obstetrics and Gynecology Clinics of North America, published by W B Saunders Co-Elsevier Inc., is a leading academic journal in the field of obstetrics and gynecology, boasting a prestigious Q1 ranking in its category as of 2023. Serving as a vital resource for clinicians, researchers, and students, the journal offers in-depth reviews and cutting-edge research that span the spectrum of women's health issues. With an impact factor reflective of its high citation rates and influence across the field, the journal encourages a comprehensive understanding of both common and complex challenges in obstetrics and gynecology. The journal has been converging high-quality research since 1987, always striving to push the boundaries of knowledge and clinical practice. Its commitment to excellence makes it an essential publication for those dedicated to advancing women's health care.

European Journal of Obstetrics & Gynecology and Reproductive Biology-X, published by ELSEVIER, serves as a pivotal platform in the fields of obstetrics, gynecology, and reproductive biology. With an ISSN of 2590-1613, this journal has developed a notable presence since its transition to Open Access in 2019, enabling wider dissemination of research findings and fostering collaboration across disciplines. Located in Amsterdam, Netherlands, this journal holds a commendable Q2 ranking in both Obstetrics and Gynecology and Reproductive Medicine categories for 2023, reflecting its impact and relevance in the scientific community. Researchers and practitioners can access cutting-edge studies and reviews, contributing to advancements in reproductive health and clinical practices. With a focus on innovative research and evidence-based practices, the European Journal of Obstetrics & Gynecology and Reproductive Biology-X is committed to bridging the gap between laboratory discoveries and the application in clinical settings, making it an essential resource for those dedicated to enhancing reproductive health outcomes.

Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.